These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18447762)

  • 1. The effect of drug consultation center guidance on contraceptive use among women using isotretinoin: a randomized, controlled study.
    Tsur L; Kozer E; Berkovitch M
    J Womens Health (Larchmt); 2008 May; 17(4):579-84. PubMed ID: 18447762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
    Boucher N; Beaulac-Baillargeon L
    Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting safe use of isotretinoin by increasing contraceptive knowledge.
    Werner CA; Papic MJ; Ferris LK; Schwarz EB
    JAMA Dermatol; 2015 Apr; 151(4):389-93. PubMed ID: 25650743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. We Pledge to Change iPLEDGE.
    Pierson JC; Ferris LK; Schwarz EB
    JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
    [No Abstract]   [Full Text] [Related]  

  • 8. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
    Pinheiro SP; Kang EM; Kim CY; Governale LA; Zhou EH; Hammad TA
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1251-7. PubMed ID: 23913625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of alternative survey methods for sensitive self-reported behaviours in a follow-up study of isotretinoin.
    Rao RS; Glynn RJ; Werler MM; Van Bennekom CM; Mitchell AA
    J Epidemiol Biostat; 2000; 5(2):133-6. PubMed ID: 10890285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.
    Landis ET; Levender MM; Davis SA; Feneran AN; Gerancher KR; Feldman SR
    J Dermatolog Treat; 2012 Aug; 23(4):272-7. PubMed ID: 22380867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
    Crijns HJ; van Rein N; Gispen-de Wied CC; Straus SM; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1060-6. PubMed ID: 22228673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with pregnancy prevention measures during isotretinoin therapy.
    Collins MK; Moreau JF; Opel D; Swan J; Prevost N; Hastings M; Bimla Schwarz E; Korb Ferris L
    J Am Acad Dermatol; 2014 Jan; 70(1):55-9. PubMed ID: 24157382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls of prescribing acne therapies including isotretinoin for pilots.
    Taibjee SM; Charles-Holmes R
    Br J Dermatol; 2008 Mar; 158(3):653-5. PubMed ID: 18205869
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
    Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
    Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
    Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
    Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study.
    Rademaker M; Wishart JM; Birchall NM
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):747-54. PubMed ID: 23617693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family physicians and accutane.
    Van Durme DJ
    Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.